Results 341 to 350 of about 9,696,955 (392)
Some of the next articles are maybe not open access.

Interleukin-6-Producing Pheochromocytoma

Acta Haematologica, 1991
A 42-year-old female with high fever and headache was admitted. Physical examination revealed hypertension, thrombocytosis with megakaryocytosis, hyperfibrinogenemia, and high level of serum noradrenaline. After operation of extramedullary pheochromocytoma, all symptoms disappeared and findings became normal.
K, Suzuki   +6 more
openaire   +2 more sources

Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus.

Critical Reviews in Eukaryotic Gene Expression, 2017
Interleukin-6 (IL-6) is a proinflammatory cytokine that decisively induces the development of insulin resistance and pathogenesis of type 2 diabetes mellitus (T2DM) through the generation of inflammation by controlling differentiation, migration ...
K. Rehman   +5 more
semanticscholar   +1 more source

Measurement of Interleukin 6

Current Protocols in Immunology, 1996
AbstractInterleukin 6 (IL‐6) is a pluripotent cytokine with multiple effects on many different cell types. It is produced by a variety of cells in response to immunological and other stimuli. This unit describes a simple and sensitive assay for human, rat, rabbit, pig, and mouse IL‐6, based on IL‐6‐dependent proliferation of a murine B cell hybridoma ...
R P, Nordan, C D, Richards, J, Gauldie
openaire   +2 more sources

Interleukin-6 and melanoma

Melanoma Research, 2012
Interleukin-6 (IL-6) is a pleiotropic immunomodulatory cytokine produced by various types of cells, including melanoma cells. IL-6 plays a major role in the pathogenesis and development of malignancies. It promotes tumour growth by inhibition of apoptosis and induces tumour angiogenesis. IL-6 is deregulated in many types of cancers, and increased serum
Hoejberg, Lise   +2 more
openaire   +3 more sources

Interleukin-6 Inhibitor: Tocilizumab

2015
Inhibitors of interleukin-6 (IL-6) are proteins which decrease the actions of the inflammatory cytokine, IL-6. Clinically, tocilizumab is the major inhibitor of IL-6. Several other proteins with IL-6 inhibitory actions (e.g., sirukumab) are being tested in clinical trials.
Pile, Kevin D.   +2 more
openaire   +3 more sources

Interleukin-6

Critical Care Medicine, 2005
Mingchen, Song, John A, Kellum
openaire   +2 more sources

Interleukin‐6

Annals of the New York Academy of Sciences, 1989
FRANK LEE   +10 more
openaire   +1 more source

Home - About - Disclaimer - Privacy